Cholestasis: Clinical Trials

8 trials for Cholestasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 unknown. 8 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Unknown 8
Phase 12Unknown 2
Phase 32Unknown 2

Follow Cholestasis: new trials by email Literature Review of Cholestasis trials Research Report on Cholestasis

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
TQA3526, Placebo to match TQA3526 - Primary Biliary Cirrhosis
Phase 2UnknownChia Tai Tianqing Pharmaceutical Group Co., Ltd.1302020-03-202020-02-20
Probiotics in PBC Patients of Poor Response to UDCA
Probiotic, Placebo - Primary Biliary Cholangitis (PBC)
Phase 2UnknownSun Yat-sen University602020-01-202020-01-07
Metformin in Intrahepatic Cholestasis of Pregnancy
Metformin, Ursodeoxycholic Acid - Intrahepatic Cholestases, Pregnancy Complications
Phase 2 / Phase 3UnknownEpsom and St Helier University Hospitals NHS Trust402019-01-012018-07-26
Pilot Study of FFP104 Dose Escalation in PBC Subjects
FFP104 - Primary Biliary Cirrhosis
Phase 1 / Phase 2UnknownFast Forward Pharmaceuticals242015-05-012016-08-24
Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
conventional plus UC-MSC treatment, Conventional plus placebo treatment - Primary Biliary Cirrhosis
Phase 1 / Phase 2UnknownBeijing 302 Hospital1002011-10-012013-05-31
Minimization of IntraLipid Versus Omegaven
Omegaven, Lipid minimization - Cholestasis, Parenteral Nutrition Associated Liver Disease (PNALD)
Phase 2 / Phase 3UnknownChildren's & Women's Health Centre of British Columbia402010-12-012011-09-07
Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease
Omegaven Therapy - Short Bowel Syndrome, Cholestasis
Phase 2UnknownAmarnath, Rathna, M.D.202009-03-012012-12-03
Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
ursodiol - Cystic Fibrosis, Gastrointestinal Diseases
Phase 2UnknownNational Center for Research Resources (NCRR)201995-11-012005-06-24

Narrower conditions

Liver Cirrhosis, Biliary (4)  ·  Cholestasis, Intrahepatic (1)  ·  Cystic Fibrosis (1)  ·  Gastrointestinal Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Inflammation (1)  ·  Pregnancy Complications (1)  ·  Rare Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Short Bowel Syndrome (1)

Broader conditions

Bile Duct Diseases (8)  ·  Biliary Tract Diseases (8)  ·  Digestive System Diseases (8)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Liver Diseases (5)  ·  Cholestasis, Intrahepatic (4)  ·  Fibrosis (4)  ·  Liver Cirrhosis (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastrointestinal Diseases (1)  ·  Infant, Newborn, Diseases (1)

Interventions

Ursodeoxycholic Acid (2)  ·  Congresses as Topic (1)  ·  Metformin (1)  ·  Probiotics (1)  ·  fish oil triglycerides (1)

Sponsors

Amarnath, Rathna, M.D. (1)  ·  Beijing 302 Hospital (1)  ·  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)  ·  Children's & Women's Health Centre of British Columbia (1)  ·  Epsom and St Helier University Hospitals NHS Trust (1)  ·  Fast Forward Pharmaceuticals (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Sun Yat-sen University (1)

Countries

China (3)  ·  United States (2)  ·  Canada (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Avash J Singh, MD (1)  ·  Bingliang Lin, MD (1)  ·  Fu-Sheng Wang, professor (1)  ·  Hassan Shehata, FRCPI, FRCOG (1)  ·  Rebecca Sherlock, MD (1)  ·  Susan Albersheim, MD, PhD (1)  ·  Terra R Varner, PharmD (1)  ·  William Balistreri (1)

Results publications

PMID 27824743, PMID 32716060

NIH funding

2014 (1)